1. Home
  2. BLND vs EOLS Comparison

BLND vs EOLS Comparison

Compare BLND & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blend Labs Inc.

BLND

Blend Labs Inc.

HOLD

Current Price

$1.66

Market Cap

411.6M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$7.73

Market Cap

384.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLND
EOLS
Founded
2012
2012
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.6M
384.6M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
BLND
EOLS
Price
$1.66
$7.73
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$4.13
$15.50
AVG Volume (30 Days)
2.2M
790.8K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
58.33
1.23
EPS
N/A
N/A
Revenue
$123,585,000.00
$297,176,000.00
Revenue This Year
$12.62
$13.27
Revenue Next Year
$14.00
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
11.61
52 Week Low
$1.18
$3.86
52 Week High
$4.49
$7.95

Technical Indicators

Market Signals
Indicator
BLND
EOLS
Relative Strength Index (RSI) 59.57 70.42
Support Level $1.60 $6.16
Resistance Level $2.05 $7.76
Average True Range (ATR) 0.10 0.33
MACD 0.02 0.12
Stochastic Oscillator 68.29 94.70

Price Performance

Historical Comparison
BLND
EOLS

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segment is Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience. The key revenue for the company is generated from the Blend Platform segment. Company has it's assets in united states, India and Mexico regions.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: